|
|
||||||||
Physiological Reviews, Vol. 79, No. 4, October 1999, pp. 1373-1430
Copyright ©1999 by the American Physiological Society
Department of Molecular Pharmacology, Diabetes and Metabolic Diseases Research Center, University Medical Center, State University of New York/Stony Brook, Stony Brook, New York
I. INTRODUCTION
II. ELEMENTS OF G PROTEIN-LINKED SIGNALING
A. G Protein-Linked Receptors
B. Heterotrimeric G Proteins
C. G Protein-Linked Effectors
D. Regulators of G Protein Signaling
III. TRANSCRIPTIONAL REGULATION OF SIGNALING PATHWAYS
A. Physiological Perspective
B. Transcriptional Activation
C. Transcriptional Repression
D. Transcriptional Basis for Physiological Regulation
IV. POSTTRANSCRIPTIONAL REGULATION OF SIGNALING PATHWAYS
A. Background
B. Destabilization of mRNA
C.-ARB Protein, a GPLR-Specific mRNA Binding Protein
D. Physiological Implications
V. POSTTRANSLATIONAL REGULATION OF SIGNALING PATHWAYS
A. Protein Phosphorylation
B. Lipid Modifications of Proteins
C. ADP-Ribosylation
VI. G PROTEIN-LINKED SIGNALING AND HUMAN DISEASES
A. GPLR-Based Diseases
B. Heterotrimeric G Protein-Based Diseases
C. Newly Emerging Therapies for G Protein Signaling Defects
VII. CLOSING COMMENTARY
| |
ABSTRACT |
|---|
|
|
|---|
Morris, Andrew J. and
Craig C. Malbon.
Physiological Regulation of G Protein-Linked
Signaling. Physiol. Rev. 79: 1373-1430, 1999.
Heterotrimeric G proteins in vertebrates
constitute a family molecular switches that transduce the activation of
a populous group of cell-surface receptors to a group of diverse
effector units. The receptors include the photopigments such as
rhodopsin and prominent families such as the adrenergic, muscarinic
acetylcholine, and chemokine receptors involved in regulating a broad
spectrum of responses in humans. Signals from receptors are sensed by
heterotrimeric G proteins and transduced to effectors such as adenylyl
cyclases, phospholipases, and various ion channels. Physiological
regulation of G protein-linked receptors allows for integration of
signals that directly or indirectly effect the signaling from
receptor
G protein
effector(s). Steroid hormones can regulate
signaling via transcriptional control of the activities of the genes
encoding members of G protein-linked pathways. Posttranscriptional
mechanisms are under physiological control, altering the stability of
preexisting mRNA and affording an additional level for regulation.
Protein phosphorylation, protein prenylation, and proteolysis
constitute major posttranslational mechanisms employed in the
physiological regulation of G protein-linked signaling. Drawing
upon mechanisms at all three levels, physiological regulation permits
integration of demands placed on G protein-linked signaling.
| |
I. INTRODUCTION |
|---|
|
|
|---|
More than a decade has passed since the highly cited review of G protein signaling by Dr. Alfred G. Gliman was published (188). Although the central elements of G protein signaling remain the cell-surface receptors coupled to G proteins, the family of nearly 20 heterotrimeric G proteins, and the ever-expanding, diverse groups of effector units [e.g., adenylyl cyclases (AC), phospholipases, various ion channels], detailing the physiological aspects of signaling through this pathways continues to stimulate and challenge us. A Medline search of the topic of G protein signaling including publications since the Gilman review reveals more than 10,000 citations relevant to the structure and function of members of the three cardinal elements of G protein signaling and how they relate to physiology as well as pathophysiology. Needless to say, the daunting challenge of covering adequately this volume of highly regarded scientific literature is surpassed only by the challenge of limiting the number of citations to 400-500 articles. Let us be explicit in stating at the outset that this review is not meant as a comprehensive analysis of all that has been published on G protein signaling in the last decade, but rather as a snapshot of a complex and large, work in progress. We shall try to highlight the nature of the basic elements constituting G protein-linked signaling and to construct a consensus for understanding how physiological regulation occurs using transcriptional, posttranscriptional, and posttranslational mechanisms well known to the molecular and cell biologist.
In an effort to anticipate criticism of our inability to include all the most relevant articles, we have created many figures and tables, richly annotated with references. Careful analysis of the citations will reveal the inclusion of many references as the most complete, and perhaps up-to-date review of the specific topic. We make no excuses that the systems adopted as "typical" for this review are highly familiar to the authors. It is true that many of the central themes described in the review could be expressed in a multitude of contexts. Because the superfamily of G protein-linked receptors will probably rise to somewhere between 500 and 1,000, few will agree with our forced selection of a given type or even subfamily of receptor for more detailed consideration of its physiological regulation. Perhaps more telling is that the challenging task of reviewing a broad field of literature does result in the emergence of "sound" from "noise," "pinnacles" from "peaks," and "timeless" from "timely" with regard to discoveries in this field. Wherever possible, these seminal discoveries and changes in how we understand or approach the study of physiological regulation of signaling via heterotrimeric G proteins are highlighted. The review is structured to illuminate the formidable tasks that lay ahead in exploitation of all that we have learned from studies of the structure and function of individual members of the troika that transduces cell membrane signals into a diverse downstream network of pathways involved in cell proliferation, differentiation, and apoptosis to a more unified understanding of the integration of these inputs.
| |
II. ELEMENTS OF G PROTEIN-LINKED SIGNALING |
|---|
|
|
|---|
A. G Protein-Linked Receptors
Evolution of our understanding of G protein-linked receptors
(GPLR) increased rapidly after the first molecular cloning of a
well-known member of the GPLR that bind hormones. In 1986, the primary sequences of the hamster (139) and turkey
(626)
-adrenergic receptors were reported, providing
long-awaited information that proved critical to understanding,
classifying, and probing GPLR. Before 1986, what we knew about GPLR was
garnered first from pharmacological studies, then radioligand binding
studies, and later through heroic efforts in protein purification of
these low-abundance membrane proteins (357,
529). The identification of seven hydrophobic sequences
similar in length and in organization to that of bacteriorhodopsin permitted modeling of GPLR and the molecular tools with which to test
many details of emerging hypotheses (Fig.
1). By the end of 1998, more than 300 members of the superfamily of hormone receptors linked to G proteins
have been entered in the GenBank. If one also includes in the listing
of GPLR the expanding subfamily of odorant receptors (69,
97), it is likely that ~1% of the mammalian genome
encodes GPLR.
|
1. Classification
Several useful approaches have been reported to the classification of GPLR. Molecular cloning provides a wealth of information, best managed as a database with automated data collection, structured flatfiles, and data query mechanisms. One such database was reported within the National Center for Biotechnology Information, first available in 1994 (307). Such databases are extremely useful tools, providing means to search homologies, to segregate paralogues (variants of receptors created by gene duplication) and orthologues (same GPLR, but different species), and to discern family, subfamilies, and other relationships among the members of this superfamily of receptors.
Using 10 residues conserved among more than a hundred different GPLR
and analysis of sequence alignment, BIN maps have been created
that can discriminate among the families based on the length of
consecutive segments, termed "partitions" (387).
Patterns of relationships develop that are provocative. The key
residues are the NH2-terminal Met termed "
," the
last nonconserved residue termed "
," and the following,
intervening conserved residues (in transmembrane-spanning regions,
see Fig. 1): Asn (TMSR1), Asp (TMSR2), Cys (top of TMR3), Arg (bottom
of TMSR3), Try (TMSR4), Cys (bottom loop between TMSR4 and TMSR5), Pro
(TMSR5), Pro (TMSR6), and Pro (TMSR7). Although only a proposed method
of analysis, BIN mapping may prove valuable in assigning identities to
orphan receptors (387).
Based simply on the chemical nature of the ligand, GPLR may be classified into families and subfamilies (537). A simple, nonexhaustive listing of the prominent members of families is provided in Table 1. Table 1 reveals the marked diversity of the ligands/stimulants toward which GPLR apparently have evolved. Visual excitation operates via GPLR signaling, relying on the capture of a photon by the 9-cis-retinal covalently coupled via Lys-296 to the opsin photopigment rhodopsin (7, 86, 134, 455, 542). The physiology and pathophysiology of vision can be explored elsewhere (422). Gustatory signals (taste) and odorant signals (smell) likewise operate via GPLR (1, 60, 365), the odorant family likely representing the most populous of all GPLR families with membership expected in the range of 1,000-2,000 receptors (22). A genetic analysis of mammalian olfaction reveals many intriguing aspects of this GPLR signaling-based sensory physiology (457). Small molecule receptors in the classification include the most well-characterized receptors for biogenic amines, such as dopamine, epinephrine, and serotonin. Included in this group are both receptors for ATP found ubiquitously in mammals (350, 356) and for cAMP, a molecule that is central to the sensory biology of Dictyostelium discoidum, the slime mold (165, 254, 380). Thus GPLR mediate the actions of a chemically diverse family of ligands (including photons) and do so in a broad spectrum of organisms, from human to mold.
The adrenergic receptors typify the relationship that can exist among
subfamilies in the GPLR superfamily (413). At least nine
adrenergic receptor paralogues have been identified. In the Ahlquist
era, a discrimination between
- and
-adrenergic agonists was
discovered. Although pharmacology created both agonists and antagonists
that collectively drove the subclassification further for both the
-
and
-adrenergic ligands, few envisioned the revelations emerging
from molecular cloning that provided no less than nine members to the
adrenergic receptor gene subfamilies (535,
536). The
-adrenergic receptor subfamily, initially
composed of the
1- and
2-members, saw the
number expand to three most recently, with the discovery of the
3-adrenergic receptor (152). The
-adrenergic subfamilies are composed of
1- and
2-adrenergic groups, with three gene products for each
(
1 with A, B, and D;
2 with A, B, and C)
(440). Molecular cloning has revealed the existence of
other subfamilies, such as the muscarinic acetylcholine receptor with
five members (343, 406, 609) and
the dopamine receptor subfamily with at least seven members
(6, 88, 124, 274, 382).
The receptor subfamily for 5-hydroxytryptamine (5-HT or serotonin) provides an impressive display of diversity (Fig. 2) (88, 94, 103, 127, 218-220). There exists at least 13 members of the rat serotonin receptor subfamily, each the product of a separate gene (161). In some cases (5-HT1B/D, 5-HT2, and 5-HT3) serotonin receptors were identified pharmacologically, before analysis by molecular cloning (219). Many, however, were generated by molecular screening of DNA libraries under low-stringency hybridization conditions. Although the sequence homology chart provides information on the extent to which various members of the subfamily of serotonin receptors display homology at the level of protein sequence, they do not reveal information on the nature of the signal propagation. Combined expression and characterization of the cloned genes will enable a methodical approach to understanding the basis and need for the many members of this subfamily of GPLR.
|
2. Structure
The
2-adrenergic receptor provides an excellent
model from which to discuss the general structure of GPLR
(530, 531, 535). The primary
sequence information deduced from the molecular cloning (139) revealed the presence of seven domains of the
sequence, rich in hydrophobic residues and spanning 22-28 residues in
length (Fig. 1). On the basis of the hydrodynamic and detergent
solubility data, it was speculated that these hydrophobic domains of
the receptor spanned the lipid bilayer of the membrane, organizing the
receptor in a fashion that resembled the deduced structure of
bacteriorhodopsin (164, 226,
469). Subsequent biochemical analysis and topographical
analysis by site-directed, antipeptide antibodies established the
NH2-terminal domain and three segments intervening between
the membrane-spanning domains as exofacial, whereas three
additional intervening segments as well as the COOH-terminal tail
of the receptor were localized to the cytoplasmic face of the lipid
bilayer (Fig. 3) (17,
589-591). Studies of N-glycosylation sites of
the
2-adrenergic receptor confirmed the location of the
NH2-terminal sequence as exofacial (181,
182). In a similar manner, study of the protein
phosphorylation of GPLR confirmed the COOH-terminal tail and the
segment between transmembrane-spanning regions 3 and 4, 5 and 6 display sites for phosphorylation by a variety of protein kinases,
including protein kinase (PK) A (222), PKC
(456), and members of the GPLR kinases, termed GRK (292, 348). The NH2-terminal
segments of GPLR vary in size from 7 to 595 amino acids and the
COOH-terminal region from 12 to 359 amino acids. Loops vary in size
from 12 to 359 amino acids. Nearly one-half of the known GPLR that
act as receptors for hormones, autacoids, and neurotransmitters also
possess a conserved protein motif, either Asp-Arg-Tyr or Glu-Arg-Trp
located in the NH2-terminal portion of the intracellular
loop between transmembrane-spanning regions 3 and 4. G
protein-linked receptors for calcitonin, CRH, growth
hormone-releasing hormone, glucagon, and parathyroid hormone lack
this motif, while retaining all of the other features discussed above
(536).
|
Although commonly displayed in the "serpentine" arrangement for the
sake of simplicity, GPLR have been shown by a number of indirect but
compelling data to be organized much like a basket composed of the
transmembrane-spanning domains (187, 235,
235, 529, 590). Photoaffinity
labeling with high-affinity antagonist ligands have revealed the
close proximity of transmembrane segments 6 and 7 with segments 1 and 2 (Fig. 4). These receptors for monoamines invariably possess an acidic side chain of Asp in
transmembrane-spanning segment 3 necessary for formation of a salt
bridge with the amino group of the ligand (531). A
hydrophobic pocket critical to binding is created by aromatic residues
of transmembrane-spanning segments 6 and 7. The hydroxyl groups of
the ligand family are believed to be hydrogen bonded through Ser and
Thr residues in transmembrane-spanning segments 4 and 5. At least
for the
2-adrenergic receptor, these data and the
overall similarity to bacteriorhodopsin (385) suggest the
existence of a binding "pocket" in which ligands interact. For the
photopigment rhodopsin, the retinal chromophore attached covalently to
Lys-296 of transmembrane-spanning segment 7 appears to be buried
~20 Å into the lipid bilayer. The hydrophobic, tryptic core of the
2-adrenergic receptor retains the ability to activate Gs in response to agonists (477). Fluorescence
energy transfer measurements with the
2-adrenergic
receptor, likewise, suggest that the binding of antagonists occurs
within the dimensions of the lipid bilayer (98,
167, 302, 338,
531), although establishing the depth to which ligands
penetrate the lipid bilayer will require more precise analysis.
|
Many GPLR bind protein ligands. The size and complexity of protein ligands for GPLR span from small peptides [thyrotropin-releasing hormone (TRH)] to large glycoproteins [luteinizing hormone (LH) and thyrotropin-stimulating hormone (TSH)] (619). Whereas the small molecule ligands may bind and activate their GPLR via a domain embedded in the bilayer, GPLR that bind protein ligands often display large NH2-terminal, exofacial domains (100, 150, 225, 265, 381, 619). There is a positive correlation between the ligand size and the GPLR NH2 terminus (266). Even more intriguing is the thrombin receptor, a substrate for the thrombin protesers carrying an NH2-terminal sequence in which its ligand is embedded (8, 57, 123, 129, 585). Cleavage of the exofacial domain of the receptors yields an activating peptide ligand, tethered to the receptor in its basal state (57, 585). Other members of this novel class of protease-activated receptors (PAR) have been cloned (57), providing an additional dimension to our understanding of ways in which GPLR can be activated. This mechanism of activation, irreversible by nature, poses some interesting possibilities about the manner in which thrombin receptors and other members of the PAR family are activated, desensitized, and downregulated (56, 57, 129, 428, 559, 561).
By definition, all GPLR not only provide the discriminator
activity for ligand binding but must propagate the activation to a G
protein(s) via protein-protein interactions (187).
First analyzed for the
1- and
2-adrenergic receptors, the NH2-terminal and
COOH-terminal extremes of the segment intervening between transmembrane-spanning regions 5 and 6 appear to play a prominent role in G protein interaction. Proteolytic cleavage products of native
receptor (433, 477, 615) and
forms of the receptor with mutations in these regions
(530, 531) provided model systems in which to
ascertain important G protein contact sites for GPLR. Mutagenesis not
only identifies regions critical to G protein coupling by GPLR, but
also reveal some residues that alter the very nature of the G proteins
to which a GPLR couples (614, 615). The early
work in the
-adrenergic receptors has been since confirmed by
similar studies in a wide variety of GPLR. Taken together, the data
provide a compelling picture of receptor-G protein contact sites
that transduce agonist binding and transformation to a receptor with high affinity for agonist into changes in G protein binding of and
activation by GTP.
B. Heterotrimeric G Proteins
1. Family classification
G proteins are members of a superfamily of GTPases that are
fundamentally conserved from bacteria to mammals and play diverse roles
in many aspects of cell regulation (190). The family of receptor-coupled G proteins has a unique heterotrimeric
composition, and there is structural and functional diversity among
each of the three polypeptide components of a G protein heterotrimer
(228, 533). In general, G proteins are
classified by reference to their 2. G protein activation and deactivation
Agonist-liganded receptors associate with and promote activation
of G proteins by stimulating release of GDP bound to the guanine
nucleotide-binding site of the G 3. Structural and functional classification of G protein
oligomers has been defined by the
-subunits, although the newly
appreciated regulatory roles for the tightly associated 
-dimers
suggest that this nomenclature should be revised to account for the
potentially complex variety of G protein heterotrimers that can be
assembled from these distinct
-,
-, and
-monomeric gene
products (105, 107, 108,
189).
-subunit. Release of GDP is
followed by GTP binding, causing dissociation of the heterotrimer into
derivative substrate
- and 
-dimer. The intrinsic GTPase activity of the
-subunit determines the lifetime of this active (dissociated) state of the G protein. Hydrolysis of bound GTP to GDP
allows the
-subunit to reassociate with the 
-dimer, ready for
another round of receptor-regulated activation (48). Both the
- and 
- subunits can regulate G protein-coupled
effectors in a selective manner that can be either independent,
synergistic, or antagonistic (408). The GTPase activity of
G
and its association with 
-subunits are both regulated by
accessory proteins. The accessory proteins involved, "regulators of G
protein signaling" have been afforded the acronym RGS proteins. The
RGS proteins may bind to G
i subunits, for example,
accelerating the rate of GTP hydrolysis (30,
32, 33, 135). The G
subunits are regulated by the protein phosducin, which binds G
tightly, preventing their interaction with G
and effectors
(39). Twenty years of biochemical and genetic studies of
the heterotrimeric G proteins have recently culminated in determination
of the three-dimensional structure of several G protein
-subunits in both their GDP- and GTP-liganded states and of a G
protein 

-heterotrimer (30, 111,
113, 298, 323, 324,
384, 515, 516, 522,
540, 557, 587). These new
structural data are treated in a later segment.
subunits are extrinsic membrane proteins. Lipid modification
generally involving myristoylation or palmitoylation at the NH2 terminus is essential for membrane anchoring of these
proteins (76, 84). Posttranslational features
of G
subunit function are detailed in section V.
-Subunits
-subunits (see Table
2). As might be expected of proteins that
perform certain highly conserved functions (for example,
association with activated hormone receptors, GTP binding, and
hydrolysis as well as association with 
-dimers), the primary
sequence of all known G
subunits contains ~20% invariant conserved amino acids. Outside of these regions, the sequences of the G
proteins diverge. Four families of these proteins, termed s, i, q, and
12/13, have been proposed based on amino acid sequence comparisons
(228, 611).
Table 2.
G protein
-subunits
The G
s class contains G
s and
G
olf, which are 88% identical (273). Both
proteins activate AC and are substrates for ADP-ribosylation catalyzed by the A1 protomer of a toxin elaborated by
Vibrio cholera (i.e., cholera toxin). This posttranslational
modification inhibits the intrinsic GTPase activity of the G proteins
(273) (see sect. VC).
The G
i class contains G
i-1,
G
i-2, G
i-3, the retinal G
,
G
t, two forms of the brain-specific G
subunit
G
o-1 and G
o-2, as well as
G
z. All members of this class (with the exception of
G
z) contain a conserved COOH-terminal cysteine
residue that is the site of ADP-ribosylation catalyzed by a toxin
elaborated by Bortadella pertussis (i.e., pertussis toxin).
This irreversible, covalent modification uncouples the G protein from
its activating receptor (see sect. VC). Blockade
of cellular responses to stimulation by pertussis toxin treatment has
been an effective experimental procedure employed to implicate this
class of G
subunits in specific cellular signaling processes. The
G
t subunit activates retinal cGMP phosphodiesterase, the
major effector in vertebrate phototransduction. Members of the
G
i and G
o subfamilies are implicated in
the regulation of ion channel activity and regulation of phospholipase
(PL) C, whereas the function of G
z is not known
(85, 349).
The G
q class contains five family members,
G
11, G
14, G
15,
G
16, and G
q. These closely related
proteins are substrates for neither cholera toxin- nor pertussis
toxin-catalyzed ADP-ribosylation. The G
q subunits
are notable regulators of the
-class of
phosphoinositide-specific PLC (PLC-
). G
q and
G
11 are widely expressed in mammalian tissues. The
expression other members of the G
q class, in contrast,
is restricted to stromal and epithelial cells as well as to cells of
the hematopoietic lineage. These G
subunits also activate PLC-
isoforms and may exhibit a preference for members of the PLC-
2 family that also display a similarly restricted
pattern of expression (4, 10,
200, 327, 328, 416,
512, 513).
The final class of pertussis toxin- and cholera toxin-resistant
G
subunits contains two proteins, G
12 and
G
13. These
-subunits are widely expressed
(510). The functions of G
12 and
G
13 have not been clearly defined. Overexpression of
activated forms of these proteins transforms fibroblasts
(312). Expression and activation of G
12 and
G
13 occurs in differentiation of P19 embryonic stem cells in response to retinoic acid (264). Activation of
G
13 leads to selective activation of
mitogen-activated protein kinases, especially jun
NH2-terminal kinases (263). Other data
implicate G
12 and G
13 in regulation of
the Na+/Cl
antiporter activity
(9, 414, 534).
4.
-Subunit/
-subunit complexes
The realization that the G
subunits play direct roles in
regulation of effectors has focused attention on these tightly associated 
-dimers (see Table 3).
Five distinct members of the G
family have been identified
(595). Each
-subunit displays 340 amino acid residues
and a molecular mass of ~35,000 Da. The linear sequence of these
proteins consists of seven or eight tandem-repeats with a central
conserved Trp-Asp sequence that has been termed a "WD-40" motif
(178). The G
family are more divergent, displaying seven family members to date, at least six of which are mammalian isoforms. These
-subunits vary in molecular masses from 7.3 to 8.5 kDa and are considerably more diverse in primary sequence than the G
subunits (30, 107, 253,
294, 408, 491). The predicted
COOH-terminal sequences of all G
subunits contain the sequence
CysAAX, where A is any aliphatic amino acids. The G
subunits are
modified by prenylation of the Cys residue by removal of the final
three amino acids by proteolysis, and then by carboxymethylation of the
newly generated COOH-terminal Cys. The retinal G
1
subunit is modified by farnesylation, whereas the other mammalian G
subunits all are modified by geranylgeranylation (see sect.
VB). This acyl chain modification is necessary
for association of the G
dimer with the lipid bilayer. G
and
G
subunits are tightly associated and cannot be dissociated except
under strongly denaturing conditions. Acylation of G
is not required
for assembly of the G
dimer, although the mechanisms by which
these proteins are assembled posttranslationally are not known.
Acylation does appear to play critical roles both in membrane
association of the G
dimer, in the association of G
with
G
, and in interactions with AC (175, 195,
253, 279, 569).
|
5. Structures of heterotrimeric G
and G
/
subunits
Structures of G
t and G
i have
been solved in their GTP-, GDP- and AlF4-liganded states
(30, 111, 113, 298,
323, 516). A mutant of G
i-1 in
which Gly-203 is substituted with Ala has been solved in its GDP and
phosphate-bound state. The structures of G
complexes with
G
i-1 and phosducin have been described (454), and a very recent study reports the structure of
the heterotrimeric catalytic core of AC complexed with
G
s (558) (Fig. 6). These structures have
provided invaluable insight into the mechanisms by which G proteins
interact with and are oriented relative to cell membranes and their
cognate receptors, as well as the processes of receptor-catalyzed
guanine nucleotide exchange, GTP hydrolysis, and effector activation.
G
subunits are composed of essentially two distinct domains, a
Ras-like GTPase domain and a predominantly helical domain that is
unique to the G
subunits. The bound guanine nucleotide is held at
the interface of these domains. Three switch regions within the GTPase
domain (switches I, II, and III) change conformation in response to the
guanine nucleotide-liganded state of the G
subunit, and
significantly, all three switch regions form significant contacts with
G
and effectors. In the GTP-bound state, the switch regions
are held in place by contacts to the terminal
-phosphate of the
nucleotide, whereas these regions appear to be less ordered (more
flexible) in crystals of the GDP-liganded G proteins (Fig. 5).
|
Structures of two G
dimers have been determined.
G
1
1 (the retinal G
species) has
been crystallized alone and in combination with either a G
subunit
or the regulator phosducin (515). A second G
dimer,
G
1
2, has been solved in the G
-bound
state (587). The G
structure is dominated by a
-propeller, which is a structural motif found in a number of
different proteins (522) (Fig.
6). This motif is composed of seven
repeats of four-stranded
-sheets that are arranged around a
small central hole. This prominent symmetry arises from the internally
repeated WD-40 motif found in the G
subunits and a functionally
diverse group of proteins. G
subunits contain a
membrane-anchoring COOH-terminal farnesyl group. G
associates
tightly with G
through a coiled-coil structure. The presence of
a region of sequence enriched in basic amino acids on the side of the
-propeller abutting this coiled-coil region suggests a possible
role in an electrostatic interaction with membrane lipids. It is
noteworthy that the G
1
1 and
G
1
2 structures differ in the relative
orientation of the coiled-coil, which may reflect differences in
interactions either with receptors or with effectors, or perhaps with
both.
|
The structures of the individual components of a G protein heterotrimer
have been augmented by descriptions of the structures of two G

complexes. The major interaction between G
and the 
-complex
involves the NH2 terminus. These structures indicate that
association with G
produces a significant change in conformation of the switch I and II regions of the G protein (Fig. 6). The structure
of G
is not appreciably changed by association with G
. This
important observation suggests that receptor-promoted guanine
nucleotide exchange alters the conformation of the switch II region of
G
, disrupting interactions that are critical for G
binding
(587). The structure of guanosine
5'-O-(3-thiotriphosphate) (GTP
S)-liganded
G
s in complex the catalytic domains of AC reveals a
unique interaction between the switch II region of the G protein and
its effector protein (Fig. 7)
(558). A number of excellent reviews discuss these
structures and the implications of the information they reveal for
understanding G protein function (215, 522).
|
C. G Protein-Linked Effectors
1. Classification
G protein
- and 
-subunits regulate the activities of a
structurally diverse group of effector molecules. These include enzymes
engaged in the synthesis and degradation of intracellular second
messengers, as well as ion-selective channels (see Table 4). In some cases, direct
regulation of these effectors by G protein subunits has been
demonstrated unequivocally by in vitro reconstitution, whereas in other
instances, a timely example being the mitogen-activated protein
kinases (MAP kinase) cascade, G protein regulation of the effectors may
be indirect. We consider these classes of G protein effectors further
below. It is also noteworthy that members of at least two
classes of G protein effectors, the PLC-
enzymes and the
cGMP-phosphodiesterases, function as GTPase-activating
proteins (RGS-like functions) for their G protein regulators.
Table 4.
G protein effectors
2. AC
Adenylyl cyclase catalyzes the formation of cAMP from the
substrate Mg2+-ATP. These enzymes are expressed in a wide
range of species from bacteria, yeasts, and slime molds to mammals. In
general, AC are membrane-bound proteins, although certain of the
bacterial and possibly mammalian enzymes are cytosolic. The yeast and
bacterial AC are peripheral membrane proteins, whereas the
Dictyostelium enzyme is an integral membrane protein with a
single transmembrane spanning domain (79). The G
protein-regulated AC isoforms identified in higher eukaryotes share
a common motif (159, 511). These enzymes are
large, single polypeptides (molecular masses in the range of 120 kDa).
In general, mammalian AC appear to be proteins embedded in the plasma
membrane. The cloning of the first of these enzymes revealed a deduced
topology that comprises an apparently duplicated structure consisting
of a short NH2 terminus, two membrane-spanning regions
of six
-helices which link ~40-kDa cytoplasmic domains (termed
domains C1 and C2). The helical portions of the transmembrane domains
are linked by short extramembranous regions. This topological organization is unique among enzymes but common to several
ATP-dependent transport proteins including the P-glycoprotein
and cystic fibrosis transmembrane conductance regulator
(18, 313). Whether or not these transmembrane
AC isoforms function as membrane transport proteins remains a
provocative question.
Complementary DNA encoding nine distinct mammalian AC isoforms have
been cloned and expressed (95, 159,
176, 258, 549). These proteins
are designated types I
IX with evidence for existence of alternatively
spliced transcripts of unknown significance, further adding to the
complexity. Homologs have been identified both in
Dictyostelium and Drosophila. The C1 and C2
domains of the mammalian AC are well conserved (50-90% identity). It
is also noteworthy that the C1 and C2 domains are homologous to each
other and to the catalytic domains of a number of membrane-bound
guanylyl cyclases (603). Catalytic activity requires both
the C1 and C2 domains, and point mutations in either of these two
domains can inhibit catalytic activity. Soluble guanylyl cyclase
isoforms function as heterodimers, and this also appears to be the case for the AC. Expression of either the NH2- and
COOH-terminal halves of the molecule or, remarkably, of the
individual C1 and C2 domains devoid of their membrane anchors
reconstitutes AC activity. These soluble AC are activated both by
G
s and by the plant diterpene forskolin
(547). Although neither the C1 nor C2 domains display sequences homologous to those involved in binding nucleotides, it is
clear that the enzyme must interact with its substrates as well as with
so-called "P-site" nucleotide regulators (272). That binding sites for these substrates and regulators are formed through the interaction between the two domains seems obvious based on
such considerations. The recently described structure of a C2 domain
homodimer revealed that forskolin and nucleotide substrates bind at the
C1/C2 domain interface (558).
Where examined, the mammalian AC isoforms are generally widely
expressed, although types I and II appear to be primarily neuronal, and
type III is restricted to olfactory epithelium (258). All forms of AC identified in mammalian systems are stimulated by GTP-liganded G
s. The enzymes differ in their
susceptibilities to regulation by 
-subunits, by members of the
G
i class, by Ca2+/calmodulin, and by PKC.

-Subunits are effective inhibitors of the type I enzyme but
stimulate activity of the type II and type IV enzymes in a manner that
is highly conditional on costimulation by G
s. It is
noteworthy that as with other 
-subunit-dependent phenomena,
stimulation of type II AC requires considerably higher concentrations
of 
-subunits than activating concentrations of
-subunits
(548, 551, 552). Thus abundant
Gi heterotrimers are likely to be the physiologically
important source of 
-subunits for this mode of regulation of AC.
Although the Gi family was initially identified as the G
proteins responsible for inhibition of AC activity, mechanisms proposed for the inhibitory mode of regulation have been the focus of intense debate. A failure to observe inhibition of adenylyl cyclase activity by
isolated G
i led to the proposition that sequestration of
G
s by 
-subunits might be the mechanism
underpinning the inhibitory response. More recent investigations reveal
that all three isoforms of G
i are equally effective
inhibitors of the types V and VI enzymes. Type I AC is selectively
inhibited by G
o, whereas the types I and V enzymes can
be inhibited by G
z (550, 551,
554).
Intracellular Ca2+ is an important regulator of AC activity. The types I, VIII, and to a lesser extent III enzymes are potently activated by Ca2+/calmodulin, whereas the other known isoenzymes are rather insensitive to this activator (598). Studies using intact cells have implicated a number of phosphorylation-dependent mechanisms in control of AC activity. Of these, control by cAMP-dependent PKA and by PKC has been most widely studied. Although both protein kinases can phosphorylate certain AC isoforms in vitro, the effects on adenylyl cyclase activity observed are modest in comparison with those observed in intact cells. It seems likely that PKA and PKC control AC activity by an indirect mechanism(s) (604).
The distinct patterns of regulation of the AC isoforms suggest that
these enzymes may function as integrators of G protein-mediated signaling pathways. Regulatory input from Gq-coupled
receptors can control AC activity by Ca2+ or
PKC-dependent processes. Gi can directly inhibit the
types I, V, and VI enzymes, whereas Gi-derived

-subunits can activate the type II enzyme in a conditional
manner. All of the AC isoforms described to date continue to share the
ability to be stimulated by GTP-loaded G
s.
3. cGMP phosphodiesterases
The cGMP phosphodiesterase (PDE) plays a central role in visual
excitation in vertebrate rod photoreceptor cells. Absorption of a
photon by the photopigment rhodopsin leads to activation of the PDE
which, in turn, catalyzes the hydrolysis of cGMP, causing closure of
cGMP-gated cation channels and in hyperpolarization of the cell
membrane (214). The cGMP PDE exists in both
membrane-bound and soluble forms. Irrespective of localization, the
protein is a heterotetramer composed of three distinct polypeptides
P
, P
, and P
with molecular masses of 88, 84, and 14 kDa,
respectively, found in a molar ratio of 1:1:2. The P
and P
polypeptides both contain catalytic sites, whereas the P
subunit is
an inhibitor of their enzymatic activities (52). The
retinal Gt protein mediates regulation of the PDE by
rhodopsin. GTP-loaded G
t binds the P
subunit,
releasing inhibition of the P
and P
catalytic subunits. P
is a
GTPase-activating protein (GAP) for G
t, increasing
its rate of GTP hydrolysis (12). Guanosine 5'-triphosphate
hydrolysis releases the P
subunit to reassociate with and to inhibit
the catalytic subunits of the enzyme, completing the
activation/deactivation cycle.
4. Inositol lipid-specific PLC
Three families of PLC enzymes classified as -
, -
, and -
have been identified in mammalian systems. There are multiple
isoenzymes within each class (464). The PLC enzymes share
some common structural features including two regions of conserved
sequence, termed "X" and "Y" domains, that contain residues
important for substrate binding and catalysis. Outside of these
sequences, the proteins diverge extensively. The four PLC-
isoenzymes are targets for activation by G
- and G
subunits.
Members of the Gq family of G protein
-subunits couple
receptors to activation of the PLC-
enzymes in a pertussis
toxin-insensitive manner (512, 555,
556). G protein regulation of the PLC-
enzymes has been
studied using both reconsititution assays with purified proteins and
exogenously provided substrates as well as by transient transfection of
COS-7 cells with vectors for the expression of the PLC enzymes and G protein subunits. Experiments using transient expression of G
subunits and PLC-
isoenzymes in COS-7 cells suggest that there are
differences in susceptibility of the individual PLC-
enzymes to
activation by the various Gq family members
(10, 416, 617, 618). However, experiments with purified
PLC-
1, -
2, and -
3 show
little difference in activation by purified G
q,
G
11, and G
16 (229,
311, 513).
In many systems, receptor regulation of inositol lipid hydrolysis is
sensitive to pertussis toxin (216). The observation that G
protein 
-subunits activate the PLC-
enzymes both in vitro and
in transient transfection assays provides a biochemical explanation for
this finding (54, 55, 78,
137, 247). 
-Subunits can activate all
of the PLC-
isoenzymes. Phospholipase C-
2 and PLC-
3 appear more sensitive to stimulation by

-subunits than PLC-
1 and PLC-
4
(430, 463). In the case of
PLC-
3, G
q and 
-subunits are
approximately equally effective activators on a molar basis. For other
members of the PLC-
family, the
q-subunits are
considerably more potent (50- to 100-fold) than G
subunits.
The PLC-
enzymes appear to function as GAP for their G protein
regulators. The G
q subunits used in these activation
experiments were liganded with nonhydrolyzable guanine nucleotide
analogs (35). Under these conditions with
GTPase-resistant GTP analogs, it is possible that the apparent
potency of
-subunits is truely an overestimate. In general, such
reconstitution studies employ G
subunits purified from bovine
brain. Since a large number of 
-dimers can be assembled from
individual members of the
- and
-subunit multigene families, it
is possible that individual G
dimers not tested may prove to be
more effective PLC activators. A limited number of studies have been
performed to test this possibility (53, 253).
With the exception of G
1
2, G
dimers
of various combinations tested appear equipotent and effective as PLC
activators. In fact, the reduced potency of G
subunits (compared
with
-subunits) as activators of the PLC-
enzymes may provide a
degree of selectivity in receptor regulation of the PLC-
enzymes.
Accordingly, only activation of abundant G protein heterotrimers (for
example, members of the pertussis toxin-sensitive Go
and Gi families) would produce sufficient 
-subunits
for activation for PLC-
by this manner.
One unique characteristic of the Gq family of
heterotrimeric G proteins is that, when purified and reconstituted with
appropriate receptors which promote the guanine nucleotide exchange
step in the G protein activation cycle, their intrinsic
steady-state GTPase activities are much lower than those of members
of the other heterotrimeric G protein families (229,
311, 426). This finding was paradoxical, since direct measurement of PLC-mediated increases in intracellular Ca2+ revealed that upon addition of an agonist, the
Gq/PLC-
system was activated extremely rapidly
(216). Ross and co-workers (34) studied regulation of PLC-
1 in a reconstituted system
containing purified M1 muscarinic cholinergic receptors and
a purified mixture of G
q and G
11. In this
system, receptor-promoted binding of GTP
S to the G protein and
PLC-catalyzed phosphatidylinositol 4,5-bisphosphate
(PIP2) hydrolysis are tightly coupled. When the nonhydrolyzable GTP
S was replaced by hydrolyzable GTP, PLC
activation was much reduced (35). This apparent uncoupling
between G protein and effector in the presence of GTP suggests that
PLC-
1 is a GAP for its G
q/11 activator
(35). Promotion of GTP hydrolysis accelerates the
deactivation rate of the G
q/11 subunits and, in turn,
accelerates the deactivation of PLC-
1. The GAP activity of PLC-
1 enables the inositol lipid signaling system to
respond rapidly to receptor deactivation. In this way, inositol
signaling is regulated not only by the rate of receptor-catalyzed
GDP/GTP exchange of the
-subunit, but also by acceleration of the
rate of GTP hydrolysis accelerated by the effector. More detailed
studies of the time courses of PIP2 hydrolysis by
PLC-
1 in this reconstitution system suggest that,
in the presence of saturating agonist, receptor-Gq complexes can remain stable over multiple GTPase cycles
(436).
All PLC enzymes contain two highly conserved X and Y domains. The
three-dimensional structure of a portion of PLC-
containing the
X and Y domains has been reported recently (153). The
other regions of the PLC enzymes display divergent sequences, focusing attention on the unique regions of the PLC-
enzymes as possible sites of G protein association. Although the precise structural nature
of the interaction between the PLC-
enzymes and G protein
- and

-subunits is not known, several lines of evidence support the
idea that these regions which comprise the NH2 terminus,
the inter X-Y region, as well as the COOH terminus play important roles in the PLC-
G protein coupling.
A number of independent experiments suggest that the COOH terminus of
the PLC-
enzymes contains sites for interaction with G protein
-subunits. Rhee and co-workers (431) reported that truncation of PLC-
1 and PLC-
2 immediately
after the Y domain produces catalytically active proteins that can be
activated by G protein 
-subunits but not by G
subunits. Simon
and colleagues (616) found that overexpression of the COOH
terminus of PLC-
1 in COS-7 cells blocked activation of
cotransfected PLC-
1 by muscarinic cholinergic receptors
and G protein
-subunits. Two short peptides corresponding to a
portion of the PLC-
1 amino acid sequence displayed the
activity to block activation of PLC-
1 by
G
q in vitro, whereas a peptide of identical amino acid
composition but different sequence did not (616). Ross and
co-workers (34, 35) found that several recombinantly expressed fragments of the COOH terminus of
PLC-
1 functioned as GAP for purified G
q
when reconstituted with purified muscarinic cholinergic receptors. The
PLC-
"tail" with the most effective GAP activity did not
correspond to the region identified as a site of G
q
interaction with PLC-
1 using the synthetic peptide approach described above (616). It is possible that the G
protein PLC-
interactions that provide the basis for stimulation of
GTPase activity and activation of PLC catalytic activity involve
different parts of the PLC-
COOH terminus. Interestingly, some of
the PLC-
COOH-terminal tails inhibited basal
PLC-
1 activity in a manner that could be overcome by
G
q. Perhaps PLC-
1 can form oligomers, and
this self-association may have some importance for the mechanism by
which G protein
-subunits activate the enzymes (436).
The site of interaction between the PLC-
enzymes and G protein

-subunits is less well defined. Because removal of the COOH terminus of PLC-
1 and PLC-
2 does not
diminish the capacity of 
-subunits to activate the enzymes, it is
reasonable to presume that the remaining portion of the enzymes contain
the 
-subunit interaction site. The X and Y domains are common to
all PLC enzymes. Therefore, the most likely sites for 
-subunit
interaction are the NH2 terminus and the inter X-Y
region. There exists experimental evidence suggesting that both of
these regions of the proteins are important for activation by

-subunits. The PLC-
and -
isoforms contain a pleckstrin
homology (PH) domain at their NH2 terminus. PH domains have
been found in a diverse group of proteins including guanine nucleotide
exchange factors for small G proteins, as well as for some protein
kinases (334). It is clear that a subset of PH domains
mediate selective interactions of proteins with inositol lipids and
phosphates (334). The PLC-
PH domain has been studied
intensely. Both intact PLC-
and the isolated PLC-
PH domain bind
PIP2 and inositol 1,4,5-trisphosphate (IP3). Binding of PIP2 to the PLC-
PH domain appears to anchor
the enzyme to the lipid bilayer, allowing it to function in a
"scooting" mode of catalysis (177). The
PLC-
1 and PLC-
2 PH domains do not appear
to serve an analogous function, since these enzymes bind to membranes
with high affinity in a manner that does not depend on
PIP2. The structure of a complex between the PLC-
PH domain and IP3 identifies amino acid residues that
participate in formation of ionic and hydrogen bonds with the inositide
headgroup. The PH domains of the PLC-
isoforms have substitutions of
key residues that interact with IP3 in the PH domains of
the
-isoform, which presumably accounts for their inability to bind
to PIP2 (480).
Studies with various other proteins suggest that some PH domains may
mediate protein interactions with G
subunits. The
-adrenergic receptor kinase (
-ARK) is recruited to the plasma membrane and activated by G
subunits (330).
-Adrenergic
receptor kinase has an NH2-terminal PH domain, and several
lines of evidence suggest that amino acid residues in the
COOH-terminal portion of this motif mediate interactions with

-subunits (29). As discussed above, the finding that
removal of the COOH terminus of the PLC-
proteins does not impair
activation by 
-subunits would be consistent with a role for the
NH2 terminus in this process. Removal of the NH2 terminus of PLC-
2 produced a
catalytically inactive protein, and there has been no direct
investigation of a role for the NH2-terminal PH domain of
the PLC-
enzymes in activation by G
subunits. Other work
implicates the highly charged residues of the inter X-Y region in
regulation of PLC-
2 by 
-subunits. Peptide
fragments from this region of PLC-